Skye Bioscience Future Growth
Future criteria checks 0/6
Skye Bioscience's earnings are forecast to decline at 26.8% per annum. EPS is expected to decline by 13.5% per annum.
Key information
-26.8%
Earnings growth rate
-13.5%
EPS growth rate
Biotechs earnings growth | 29.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 09 Sep 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -52 | -45 | -37 | 3 |
12/31/2025 | N/A | -40 | -29 | -30 | 4 |
12/31/2024 | N/A | -31 | -28 | -25 | 4 |
6/30/2024 | N/A | -42 | -20 | -20 | N/A |
3/31/2024 | N/A | -37 | -15 | -15 | N/A |
12/31/2023 | N/A | -38 | -14 | -14 | N/A |
9/30/2023 | N/A | -43 | -15 | -15 | N/A |
6/30/2023 | N/A | -21 | -13 | -13 | N/A |
3/31/2023 | N/A | -22 | -14 | -14 | N/A |
12/31/2022 | N/A | -19 | -13 | -13 | N/A |
9/30/2022 | N/A | -12 | -10 | -10 | N/A |
6/30/2022 | N/A | -11 | -9 | -9 | N/A |
3/31/2022 | N/A | -9 | -8 | -8 | N/A |
12/31/2021 | N/A | -9 | -7 | -6 | N/A |
9/30/2021 | N/A | -8 | -6 | -6 | N/A |
6/30/2021 | N/A | -7 | -7 | -7 | N/A |
3/31/2021 | N/A | -6 | -6 | -6 | N/A |
12/31/2020 | N/A | -7 | -6 | -6 | N/A |
9/30/2020 | N/A | 0 | -6 | -6 | N/A |
6/30/2020 | N/A | -4 | -5 | -5 | N/A |
3/31/2020 | N/A | 13 | -6 | -6 | N/A |
12/31/2019 | N/A | 1 | -6 | -6 | N/A |
9/30/2019 | N/A | -10 | -6 | -6 | N/A |
6/30/2019 | N/A | -7 | -5 | -5 | N/A |
3/31/2019 | N/A | -26 | -4 | -4 | N/A |
12/31/2018 | N/A | -19 | -4 | -4 | N/A |
9/30/2018 | N/A | -14 | -5 | -5 | N/A |
6/30/2018 | N/A | -12 | -4 | -4 | N/A |
3/31/2018 | N/A | -10 | N/A | -4 | N/A |
12/31/2017 | N/A | -4 | N/A | -3 | N/A |
9/30/2017 | N/A | -5 | N/A | -2 | N/A |
6/30/2017 | N/A | -5 | N/A | -2 | N/A |
3/31/2017 | N/A | -4 | N/A | -3 | N/A |
12/31/2016 | N/A | -4 | N/A | -4 | N/A |
9/30/2016 | N/A | -3 | N/A | -4 | N/A |
6/30/2016 | N/A | -3 | N/A | -5 | N/A |
3/31/2016 | N/A | -6 | N/A | -4 | N/A |
12/31/2015 | N/A | -5 | N/A | -4 | N/A |
9/30/2015 | N/A | -6 | N/A | -3 | N/A |
6/30/2015 | N/A | -6 | N/A | -3 | N/A |
3/31/2015 | N/A | -4 | N/A | -3 | N/A |
12/31/2014 | N/A | -3 | N/A | -2 | N/A |
9/30/2014 | N/A | -1 | N/A | -1 | N/A |
6/30/2014 | N/A | 0 | N/A | 0 | N/A |
3/31/2014 | N/A | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SKYE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SKYE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SKYE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if SKYE's revenue is forecast to grow faster than the US market.
High Growth Revenue: SKYE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SKYE's Return on Equity is forecast to be high in 3 years time